Filing Details
- Accession Number:
- 0001181431-12-008688
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2012-02-14 16:28:16
- Reporting Period:
- 2012-01-23
- Filing Date:
- 2012-02-14
- Accepted Time:
- 2012-02-14 16:28:16
- Original Submission Date:
- 2012-01-23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1429260 | Coronado Biosciences Inc | CNDO | Pharmaceutical Preparations (2834) | 205157386 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 941841 | Md A Lindsay Rosenwald | C/O Coronado Biosciences, Inc. 15 New England Executive Park Burlington MA 01803 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.001 Per Share | Acquisiton | 2012-01-23 | 2,000 | $6.95 | 2,459,001 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase Common Stock | Acquisiton | 2010-10-05 | 25,000 | $0.00 | 25,000 | $1.37 |
| Common Stock | Warrants to purchase Common Stock | Acquisiton | 2009-01-22 | 4,529 | $0.00 | 4,529 | $9.23 |
| Common Stock | Warrants to purchase Common Stock | Acquisiton | 2009-05-28 | 2,265 | $0.00 | 2,265 | $9.23 |
| Common Stock | Warrants to purchase Common Stock | Acquisiton | 2009-06-24 | 566 | $0.00 | 566 | $9.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,000 | 2020-10-05 | No | 4 | A | Direct | |
| 4,529 | 2014-01-22 | No | 4 | A | Indirect | |
| 2,265 | 2014-05-28 | No | 4 | A | Indirect | |
| 566 | 2014-06-24 | No | 4 | A | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, Par Value $.001 Per Share | 170,983 | Indirect | By Capretti Grandi, LLC |
| Common Stock, Par Value $.001 Per Share | 453,822 | Indirect | By LAR Family Trusts |
| Common Stock, Par Value $.001 Per Share | 742,861 | Indirect | By Paramount Biosciences |
| Common Stock, Par Value $.001 Per Share | 100,000 | Indirect | Island Irrevocable Trust U/T/A/ DTD 8-28-01 |
| Common Stock, Par Value $.001 Per Share | 80,000 | Indirect | By The Lindsay A. Rosenwald Alaska Irrevocable Trust U/T/A DTD 8-29-01 |
| Common Stock, Par Value $.001 Per Share | 720,000 | Indirect | By The Lindsay A. Rosenwald 2000 Irrevocable Trust U/T/A DTD 5-24-00 |
| Common Stock, Par Value $.001 Per Share | 100,000 | Indirect | By The Lindsay A. Rosenwald Nevada Irrevocable Indenture of Trust U/T/A/ DTD 8-29-01 |
Footnotes
- Includes shares of common stock issued on November 15, 2011 pursuant to the automatic conversion of preferred stock held by the Reporting Person.
- One-third of the shares will vest on each of October 5, 2011, 2012 and 2013.
- Immediately.
Billionaire Hedge Funds
